Press release
AI-Powered Imaging Diagnostics Market to Reach US$ 9.73 Billion by 2033 as Radiology, CT, MRI and X-Ray Workflows Move Toward AI-Assisted Diagnosis
AI-Powered Imaging Diagnostics Market
Request Executive Sample | Market Intelligence: https://www.datamintelligence.com/download-sample/ai-powered-imaging-diagnostics-market?kailas
2026 Official Developments in Imaging AI Clearances, Algorithm Launches and Hospital Deployments
Several 2026 official developments show how imaging diagnostics software is shifting toward regulated, deployable and workflow-connected platforms:
1. Qure.ai announced six additional FDA-cleared indications for qXR-Detect in February 2026, following an FDA decision in January 2026; the company said the clearance expanded its total FDA-cleared indications to 26 and included a Predetermined Change Control Plan for chest X-ray detection.
2. Philips received FDA clearance for its Spectral CT Verida Family in March 2026 and announced Verida in April as an AI-powered detector-based spectral CT platform designed for radiology, cardiology and oncology use cases.
3. The FDA's AI-enabled medical device list added Infervision's InferCare RECIST in March 2026, underscoring continued regulatory activity around oncology imaging assessment and quantitative radiology tools.
4. deepc and DeepTek announced an integrated radiology AI partnership in April 2026, combining deepcOS and Augmento into an operating environment for deployment, orchestration and governance of clinical AI across radiology workflows.
5. Brainomix launched its next-generation Brainomix 360 Stroke platform in 2026 with net water uptake technology and listed a major deployment across WVU Health System sites, highlighting the role of stroke imaging AI in network-wide care pathways.
6. Rad AI announced a 2026 strategic partnership with Yale New Haven Health System to deploy its radiology automation tools across more than 16 outpatient imaging centers and five hospital campuses.
Radiology Capacity Pressure Creates the Buying Case
The strongest commercial story behind the AI-powered imaging diagnostics market is not only accuracy; it is capacity. Imaging demand continues to rise while radiologist staffing remains constrained, creating pressure on turnaround time, subspecialty coverage and after-hours interpretation. The American College of Radiology has described workforce shortages and rising imaging volumes as central stress points for radiology practices, which makes triage automation and disease-specific AI diagnostic algorithms more relevant to procurement teams.
In practical terms, AI radiology tools are being evaluated for where they can change workflow: flagging suspected intracranial hemorrhage, pulmonary embolism, lung nodules, fractures, stroke findings, breast abnormalities and oncology response markers before a final read. This positions AI as a reading-room coordination layer rather than a replacement for clinical judgment.
Request a Customized Report According to Your Business Strategy: https://www.datamintelligence.com/customize/ai-powered-imaging-diagnostics-market?kailas
Drivers, Disruption and Opportunity Areas
Market demand is being driven by higher scan volumes, specialist shortages, oncology and cardiology imaging demand, aging populations and the need to standardize quality across multi-site imaging networks. Hospitals are also looking for tools that can prioritize urgent cases, reduce missed findings, automate measurements and support consistency in follow-up imaging.
The disruption is equally clear. AI validation, interoperability with PACS/RIS systems, local workflow fit, reimbursement, cybersecurity, explainability and clinician trust remain barriers. FDA guidance on AI-enabled device change-control plans and international transparency principles from FDA, Health Canada and the UK MHRA show that regulators are pushing the sector toward lifecycle oversight, clearer user information and safer model updates.
Opportunities are strongest in triage, detection, workflow orchestration and multimodal imaging. Buyers increasingly prefer platforms that can manage multiple algorithms across modalities, rather than isolated single-use tools. OECD work on digital health and AI also points to the need for stronger evaluation, governance and health-system readiness before AI can scale responsibly.
Segmentation and Regional Demand
DataM segments the market by component into software, hardware and services; by modality into CT, X-ray, MRI, ultrasound, mammography, PET and others; by application into radiology, cardiology, ophthalmology, oncology, neurology, orthopedics, dentistry and others; and by end user into hospitals, specialty clinics, diagnostic centers, research and academic institutes and other settings. DataM also identifies radiology as the dominant application area and North America as a significant regional market.
The USA remains the most mature access point because of FDA AI-device pathways, large imaging networks and early hospital adoption of radiology automation. Japan's relevance is tied to SaMD oversight and Medical DX programs focused on healthcare information platforms, electronic record standardization and operational efficiency. Germany matters as a European hospital technology and software-infrastructure market where platform integration, compliance and clinical validation can shape adoption. South Korea combines medical-device AI guidance with national healthcare AI programming, creating a favorable environment for regulated diagnostic software.
Purchase Corporate License | Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=ai-powered-imaging-diagnostics-market?kailas
Competitive Landscape and Official Company Profiles
DataM lists key players including deepc GmbH, Qure.ai Technologies, DeepTek.ai, Philips, Tempus AI, Rayscape, Infervision, AIKENIST, Rad AI and Brainomix. Competition is moving toward three layers: algorithm performance, workflow integration and governance-ready deployment.
Philips is positioned through imaging hardware, AI reconstruction and modality-integrated software. Its 2026 Verida and Rembra CT developments show how modality vendors are embedding AI deeper into scanners and reconstruction workflows, which can make AI adoption less dependent on standalone software procurement.
Qure.ai competes through disease-specific imaging algorithms across chest X-ray, CT and emergency imaging workflows. Its 2026 qXR-Detect clearance expansion matters because it broadens the number of chest radiography findings that can be flagged in a high-volume modality.
deepc and DeepTek.ai address the platform side of medical imaging AI. deepcOS focuses on connecting, deploying, monitoring and governing AI workflows, while DeepTek's Augmento platform supports radiology workflow automation. Their 2026 partnership reflects a broader market shift from individual algorithms to integrated AI operating environments.
Brainomix is differentiated by neurological imaging, particularly stroke. Its next-generation Brainomix 360 Stroke platform and health-system deployment activity show why time-sensitive disease areas remain commercially attractive: the value proposition is tied directly to triage, treatment eligibility and network-wide clinical coordination.
Conclusion
The AI-powered imaging diagnostics market is becoming a capacity and governance market, not just an algorithm market. Hospitals will measure ROI through faster triage, fewer workflow bottlenecks, improved subspecialty support, standardized reporting and better use of scarce radiology expertise. The winning vendors will be those that combine validated AI diagnostic algorithms with seamless PACS integration, transparent performance monitoring and clinical governance that radiologists can trust.
Read Exclusive Report Description: https://www.datamintelligence.com/research-report/ai-powered-imaging-diagnostics-market
Contact:
Fabian Mathew
DataM Intelligence 4market Research LLP
6th Floor, M2 Tech Hub, DataM Intelligence 4market Research LLP, Lalitha Nagar, Habsiguda, Secunderabad, Hyderabad, Telangana 500039
USA: +1 877-441-4866
Email: fabian@datamintelligence.com
About DataM Intelligence
DataM Intelligence is a global market research and business intelligence firm delivering actionable insights across healthcare, pharmaceuticals, chemicals, energy, technology, food, and industrial sectors. Through syndicated reports, custom research, consulting, and competitive intelligence services, the company helps organizations identify growth opportunities, navigate market challenges, and make informed strategic decisions in over 50+ countries worldwide.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release AI-Powered Imaging Diagnostics Market to Reach US$ 9.73 Billion by 2033 as Radiology, CT, MRI and X-Ray Workflows Move Toward AI-Assisted Diagnosis here
News-ID: 4573221 • Views: …
More Releases from DataM intelligence 4 Market Research LLP
3D Food Printing Market Size to Reach USD 10.21 Billion by 2035 as Personalized …
According to DataM Intelligence, the global 3D food printing market size was valued at USD 5.358 billion in 2025 and is projected to reach USD 10.21 billion by 2035, expanding at a CAGR of 34.3% during 2026-2035. The 3D food printing market size is gaining attention as food manufacturers, restaurants and healthcare providers explore customized preparation, controlled portions and digitally designed food products.
The 3D food printing industry is moving…
Underground Mining Vehicles Market Size to Reach USD 13.7 Billion by 2035 as Bat …
According to DataM Intelligence, the underground mining vehicles market was valued at USD 7.29 billion in 2025 and is projected to reach USD 13.7 billion by 2035, growing at a CAGR of 6.01% during 2026-2035. Mining companies are changing the way they evaluate underground vehicle fleets. Instead of focusing only on engine power, payload capacity and acquisition cost, operators now consider ventilation expenses, energy efficiency, automation readiness, maintenance requirements and…
Monorail Systems Market Size to Reach USD 14.22 Billion by 2032, as Smart Urban …
According to DataM Intelligence, the global monorail systems market was valued at USD 9.45 billion in 2025 and is projected to reach USD 14.22 billion by 2032, growing at a 6.02% CAGR during the forecast period. Electric propulsion dominates the industry with an 87.8% share, while Asia-Pacific accounts for 42% of global revenue, supported by large-scale urban transit investments and expanding rail infrastructure.
Monorail systems are no longer viewed as…
Top and Emerging Biofuels Market Gains Commercial Pull to USD 85.72 Billion by 2 …
According to DataM Intelligence, the global top and emerging biofuels market was valued at USD 53.45 billion in 2025 and is projected to reach USD 85.72 billion by 2032, expanding at a 7% CAGR during 2026-2032. Ethanol accounted for 61.5% of the market, while biodiesel represented 38.5%, with North America leading global demand and Asia-Pacific emerging as the fastest-growing regional market.
Global procurement teams are facing a growing challenge that…
More Releases for FDA
FDA vs Non-FDA Freeze-Dried Fruit Suppliers: Risk and Market Access Differences
FDA Freeze-Dried Fruit Suppliers vs Non-FDA Approved Producers: Risk and Market Access Differences
Fujian Lixing Food Co., Ltd. - an internationally acclaimed provider of FDA freeze dried fruits and a pioneer in vacuum sublimation technology - today provided an insightful analysis that illuminated critical differences between FDA-registered suppliers and non-approved producers; with rising consumer demand for "clean label" healthy snacks a must, this study illustrates why regulatory compliance must be adhered…
DreaMed receives 5th FDA Clearance
TEL AVIV, Israel: DreaMed Diabetes LTD. ("DreaMed" or the "Company"), developer of the endo.digital Clinical Decision Support System announced today that it has received its 5th U.S Food and Drug Administration (FDA) clearance that expands the scope of AI enhanced treatment recommendations to patients on fixed meal insulin regimens. endo.digital is the first decision support system that has been cleared to assist healthcare providers in the management of diabetes…
FDA Compliant Blood Storage and Preservation
Accsense Monitoring System Automates Data Archive and Alarming
CAS DataLoggers provided the temperature alarming and monitoring system to a hospital blood bank looking to replace their old paper chart recorders as they became unreliable and spare parts were harder to find. For proper blood storage and preservation, the lab’s medical units needed to maintain storage temperatures between 2°C to 6°C (36°F to 43°F), given the perishability of blood components. The facility…
New FDA Design Control Training Courses
Salt Lake City, Utah - February 23 2017 - Procenius Consulting is a medical device consulting firm specializing solely in medical device design controls regulation (21 CFR 820.30).
Announcing New Design Control Training Courses
Procenius Consulting has just launched two new training courses covering basic and advanced topics of medical device design control regulation. These courses focus on compliance, practical implementation and industry best practices techniques for developing or improving a…
fda online training
GRC Training Solutions provides end-to-end FDA compliance solutions for those companies who want to maximize security, minimize operational costs, improve staff productivity and stay on top of all their compliance documentation.
GRC Training Solutions boasts a team of experts and specialists who have a proven track record in working with the biotechnology, medical device, diagnostic and pharmaceutical fields. Our team will work with you closely and develop solutions that meet…
FDA online training
Description:
Device firms, establishments or facilities that are involved in the production and distribution of medical devices intended for use in the U.S are required to register annually. Most establishments that are required to register with the FDA are also required to list the devices that are made there and the activities that are performed on those devices. Initially, FDA issued a 28-page Proposed Rule that would amend its regulations regarding…
